Poor clinical outcome of relapsed/refractory diffuse large B-cell lymphoma with MYC translocation treated with polatuzumab vedotin, bendamustine, and rituximab
Article in Journal of Clinical and Experimental Hematopathology (July 2023)
The most recent citing publications are shown below. View all 9 publications that cite this research output on Dimensions.
Article in Journal of Clinical and Experimental Hematopathology (July 2023)
Book chapter (January 2023)
Article in Antibodies (December 2022)